Psychedelic Brain · 迷幻研究文獻日報

📅 2026年5月2日(週六) 📊 12 篇文獻 Powered by PubMed + Zhipu AI

📋 今日文獻趨勢

今日共收錄 12 篇迷幻研究文獻。

今日精選 TOP Picks
📚其他值得關注的文獻
📄

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Based on its in vitro profile and preliminary evidence, 4-bromo-2,5-dimethoxyphenethylamine (2C-B) may have psychoactive properties that are similar t

📄

Psychedelics as a potential treatment for borderline personality disorder: A narrative review.

Psychiatry research

Borderline personality disorder (BPD) is a serious mental illness with high rates of morbidity and stigma; however, successful remission is frequently

📄

The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting Na

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Δ⁹-Tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, is widely recognized for its central effects mediated by cannabinoid rec

📄

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis.

Addiction (Abingdon, England)

AIM: To monitor community-level consumption of 20 illicit drugs across urban areas of England using wastewater-based epidemiology (WBE) surveillance a

📄

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

International journal of methods in psychiatric research

OBJECTIVES: For English, the validated part of Psychedelic Experience Scale (PES48) is a four-factor structure called the Mystical Experience Question

📄

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Schizophrenia research

Serotonergic psychedelics are re-emerging as therapeutic candidates across psychiatry, particularly for treatment-resistant depression. Their rapid an

📄

Associations between substance use treatment and ketamine use: A hypothesis-generating analysis.

Addictive behaviors reports

BACKGROUND: Ketamine is increasingly used in clinical settings for mental health and pain management, yet its misuse poses public health risks. While

🏷️關鍵字
psychedelicpsilocybinMDMA
🏥 李政洋身心診所首頁